MaxCyte, Inc.
MXCT
$1.04
-$0.05-4.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.65M | 7.30M | 6.83M | 8.51M | 10.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.65M | 7.30M | 6.83M | 8.51M | 10.39M |
| Cost of Revenue | 1.57M | 1.61M | 1.60M | 1.52M | 1.50M |
| Gross Profit | 8.08M | 5.69M | 5.23M | 6.99M | 8.89M |
| SG&A Expenses | 9.39M | 8.24M | 9.96M | 13.87M | 14.22M |
| Depreciation & Amortization | 1.02M | 1.04M | 1.04M | 1.08M | 1.06M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.84M | 14.22M | 17.92M | 22.73M | 22.69M |
| Operating Income | -6.19M | -6.92M | -11.09M | -14.23M | -12.30M |
| Income Before Tax | -4.75M | -9.60M | -12.42M | -12.36M | -10.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.75M | -9.60M | -12.42M | -12.36M | -10.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.75M | -9.60M | -12.42M | -12.36M | -10.26M |
| EBIT | -6.19M | -6.92M | -11.09M | -14.23M | -12.30M |
| EBITDA | -5.14M | -5.86M | -10.03M | -13.14M | -11.20M |
| EPS Basic | -0.04 | -0.09 | -0.12 | -0.12 | -0.10 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.05 | -0.07 | -0.06 |
| EPS Diluted | -0.04 | -0.09 | -0.12 | -0.12 | -0.10 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.05 | -0.07 | -0.06 |
| Average Basic Shares Outstanding | 106.88M | 106.73M | 106.61M | 106.40M | 105.95M |
| Average Diluted Shares Outstanding | 106.88M | 106.73M | 106.61M | 106.40M | 105.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |